News

MedUni Vienna: Cured hepatitis C with advanced liver disease: cancer risk remains

12. MedTec Summer Academy: Medizintechnik im Herzen des Waldviertels

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates

IMC Krems: Forschungsprojekt zur Entwicklung optogenetischer Stammzelllinien erfolgreich - "Lichtschalter" für spezielle Rezeptoren entwickelt

vetmeduni: Caripe 8: Wiener Forschungsteam identifiziert neuen Anti-Krebswirkstoff

LBI: MICSE guidelines published in “Cell” provide a universal toolset for cellular senescence in vivo research

MedUni Vienna: New method for diagnosing and monitoring COVID-19 severity

AOP Health New Cancer Trial

QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform

MedUni Vienna: Heart failure in type 2 diabetes: Current diagnostic methods unreliable in women

MedUni Vienna: New insights into cellular processes after a stroke

SAN Group ernennt neuen Chief Financial Officer sowie Chief Sales and Marketing Officer

Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’s Most Clinically Advanced Tetravalent Shigella Vaccine Candidate

Sandia National Laboratories acquire second Lithoz CeraFab printer to ramp up their R&D scale of additively manufactured ceramic parts

University of Vienna: The Next Generation of RNA Chips

ÖGP: Welt-Lungenkrebstag: „Zukunftsmusik“ spielt im Hier und Jetzt

MedUni Vienna: Gastric cancer - Biomarkers identified to predict the risk of relapse

MedUni Vienna: Climate change and "new" allergy triggers extend pollen season

Wiener Gesundheitsverbund und die Vinzenz Gruppe Wien setzen auf digitalen Bildaustausch

Cancer Mission Lab des Open Innovation in Science Center der LBG: Förderempfehlung für drei innovative Projekte